AbbVie
ABBV
#30
Rank
โ‚ฌ299.34 B
Marketcap
169,40ย โ‚ฌ
Share price
2.37%
Change (1 day)
22.19%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

P/S ratio for AbbVie (ABBV)

P/S ratio as of December 2024 (TTM): 5.59

According to AbbVie's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 51.2. At the end of 2024 the company had a P/S ratio of 6.20.

P/S ratio history for AbbVie from 2012 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20246.2023%
20235.042.32%
20224.9215.58%
20214.263.14%
20204.134.92%
20193.94-5.43%
20184.16-23.93%
20175.4737.85%
20163.97-4.86%
20154.17-20.04%
20145.2216.95%
20134.4651.93%
20122.94

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
2.49-55.54%๐Ÿ‡บ๐Ÿ‡ธ USA
2.42-56.70%๐Ÿ‡บ๐Ÿ‡ธ USA
17.1 206.47%๐Ÿ‡บ๐Ÿ‡ธ USA
4.40-21.25%๐Ÿ‡บ๐Ÿ‡ธ USA
4.09-26.83%๐Ÿ‡บ๐Ÿ‡ธ USA
2.22-60.24%๐Ÿ‡บ๐Ÿ‡ธ USA
1.74-68.92%๐Ÿ‡ฌ๐Ÿ‡ง UK
4.03-27.92%๐Ÿ‡ฌ๐Ÿ‡ง UK
6.15 9.94%๐Ÿ‡บ๐Ÿ‡ธ USA